Overdose deaths involving psychostimulants reached 32,537 in the United States. Methamphetamine dependence develops in half of regular users within one year. Figures on prevalence, physiological effects, and treatment outcomes map the full extent of the patterns.
Key Takeaways
- Stimulant use disorder remission rate without treatment is 10% per 1-year follow-up
- Stimulants increase heart rate by 20-50 beats per minute acutely per NIDA research
- US economic cost of cocaine use: $193 billion annually including addiction treatment per RAND
- In 2021, an estimated 2.7 million people aged 12 or older in the US misused prescription stimulants in the past year according to NSDUH data
- Stimulants induce euphoria but paranoia in 40% of users after 24 hours per self-report
Stimulant use remains common, with notable prevalence differences across age and regions.
Related reading
01 · Category
Addiction and Overdose26 stats
01
Stimulant use disorder remission rate without treatment is 10% per 1-year follow-up
02
Cocaine use disorder lifetime prevalence is 2.8% in US per NESARC-III
03
Methamphetamine dependence develops in 50% of regular users within 1 year per NIDA
04
Overdose deaths involving psychostimulants rose 37% from 2020-2021 to 32,537 in US per CDC
05
Amphetamine-type stimulants involved in 20% of global drug treatment admissions per UNODC 2023
06
Cocaine overdose mortality rate is 1.8 per 100,000 population in US 2021 per CDC WONDER
07
61% of meth users meet DSM-5 criteria for severe dependence per PATH study
08
Stimulant use disorder has 12-month prevalence of 0.4% in US adults per NSDUH 2021
09
Fentanyl-stimulant co-overdoses accounted for 27% of US drug deaths in 2022 per CDC
10
Relapse rate within 1 year for cocaine addiction is 60-90% per NIDA meta-analysis
11
Methamphetamine seizures increased 500% from 2013-2022 globally per UNODC, indicating supply fueling addiction
12
25% of prescription stimulant misusers develop dependence within 2 years per NESARC
13
Overdose from caffeine pills exceeds 100mg/kg lethal dose in 50% fatal cases per toxicology
14
MDMA-related deaths rose to 150 in Europe 2022 per EMCDDA, mostly overdose/poly
15
Severity of stimulant dependence correlates with 4-fold crime increase per criminology study
16
US ED visits for stimulant overdose up 45% 2019-2022 to 140,000 annually per DAWN
17
Khat dependence prevalence 10-20% among regular users in Yemen per WHO
18
40% of meth addicts inject, raising HIV/HCV risk 10-fold per IDU studies
19
Cocaine addiction treatment dropout rate is 50% within 3 months per TC studies
20
Annual US cocaine overdose deaths: 24,000 in 2021 per CDC NVSS
21
Amphetamine use disorder recovery rate with CM therapy: 40% abstinence at 6 months per RCT
22
Stimulant polysubstance use in 70% of overdose decedents per autopsy data
23
Meth dependence heritability estimated at 50% per twin studies
24
Global ATS treatment demand up 20% 2017-2022 per UNODC
25
15% of US adults with ADHD misuse stimulants leading to dependence per cohort
26
Nicotine addiction onset in 70% of first-time smokers within weeks per NIDA
Interpretation
Addiction and Overdose Interpretation
Left to their own devices, nine out of ten people with a stimulant disorder remain trapped, yet a staggering web of rising supply, devastating health risks, and brutally low remission rates proves this is not a battle of willpower but a systemic crisis demanding urgent, compassionate intervention.
02 · Category
Physiological Effects29 stats
01
Stimulants increase heart rate by 20-50 beats per minute acutely per NIDA research
02
Cocaine use elevates blood pressure by up to 30% within minutes per NIH study
03
Methamphetamine causes hyperthermia with body temperature rising 2-4°C per CDC report
04
Amphetamines reduce appetite leading to 10-20% body weight loss over months per meta-analysis
05
Chronic stimulant use leads to 25% reduction in dopamine transporter density in brain per PET scans
06
Caffeine at 200mg increases alertness but raises cortisol by 30% per endocrine study
07
Cocaine constricts coronary arteries by 20-40% causing ischemia per cardiology review
08
MDMA increases serotonin release by 900% and dopamine by 300% acutely per neuroimaging
09
Stimulant-induced bruxism occurs in 40-60% of chronic users per dental study
10
Methamphetamine use correlates with 3-fold increase in stroke risk under age 45 per meta-analysis
11
Prescription stimulants like Adderall increase systolic blood pressure by 5-10 mmHg chronically
12
Nicotine as stimulant raises heart rate by 15-25 bpm within seconds per pharmacology text
13
Chronic cocaine use causes cardiomyopathy in 20-30% of heavy users per echo studies
14
Amphetamine-induced vasoconstriction reduces skin blood flow by 50% per laser Doppler
15
Stimulants elevate body temperature to 40°C+ in 15% of overdose cases per toxicology data
16
Khat chewing increases salivary amylase by 40% indicating stress response per biochemical study
17
Methamphetamine accelerates atherosclerosis by 2-3 years per vascular imaging
18
Caffeine 400mg/day causes diuresis increasing urine output by 20% per renal study
19
Cocaine use precipitates ventricular arrhythmias in 10% of users with heart disease per EP study
20
Chronic stimulant abuse leads to 15% decrease in gray matter volume in prefrontal cortex per MRI
21
Adderall increases pupil dilation by 20-50% dose-dependently per pupillometry
22
Stimulants boost metabolic rate by 5-15% for hours post-dose per calorimetry
23
Meth causes rhabdomyolysis in 5-10% of ED presentations per case series
24
Cocaine elevates plasma norepinephrine by 300-500% acutely per catecholamine assay
25
Chronic amphetamine use impairs insulin sensitivity by 25% per OGTT studies
26
MDMA induces hyponatremia in 4% of users due to SIADH per festival studies
27
Stimulants like ephedrine increase intraocular pressure by 3-5 mmHg per glaucoma research
28
Cocaine causes platelet aggregation increase by 50% promoting thrombosis per hematology
29
Methamphetamine use linked to 40% higher HIV viral loads in infected users per cohort study
Interpretation
Physiological Effects Interpretation
Stimulants are essentially a hostile corporate takeover bid for your body, presenting an immediate and flashy dividend of heightened performance while quietly hollowing out your cardiovascular, neurological, and metabolic infrastructure through a relentless campaign of chemical asset-stripping.
03 · Category
Policy and Treatment24 stats
01
US economic cost of cocaine use: $193 billion annually including addiction treatment per RAND
02
Methamphetamine treatment admissions in US: 190,000 in 2021 per TEDS
03
Contingency management boosts stimulant abstinence by 50% vs standard care per meta-analysis
04
US Schedule II stimulant prescriptions totaled 50 million in 2022 per IQVIA
05
CBT for cocaine dependence yields 60% reduction in use days at 12 weeks per NIDA CTN
06
Global ATS seizures: 1,200 tons in 2022 per UNODC, policy impact on supply
07
US opioid-stimulant co-use treatment programs increased 30% 2018-2022 per SAMHSA
08
Modafinil FDA-approved for narcolepsy but off-label stimulant cessation aid in 20% trials success
09
Australian meth treatment cost per person: AUD 25,000/year per NDARC
10
US DAWN reported 1.1 million ED visits for stimulants 2021 costing $10B in care
11
Matrix model for stim addiction achieves 70% retention vs 40% standard per UCLA study
12
EU early warning system flagged 50 new stimulants 2022 per EMCDDA policy
13
Bupropion 150mg aids smoking cessation in 30% vs 15% placebo per meta-analysis
14
US criminal justice referrals for stim treatment: 35% of total drug cases per TEDS 2021
15
Varenicline doubles nicotine quit rates to 25-30% at 1 year per Cochrane review
16
Canadian prescription monitoring reduced stimulant diversion by 15% 2015-2020 per Health Canada
17
CMI-135 trial for cocaine addiction showed 40% abstinence with vaccine per phase II
18
Workplace drug testing detects stimulants in 1.5% of US tests per Quest Diagnostics 2022
19
Telehealth stim treatment uptake rose 400% post-COVID per SAMHSA 2022
20
UK drug strategy allocated £900M for stim addiction services 2021-2025 per gov.uk
21
12-step programs yield 20% 1-year abstinence for stim users per large cohort
22
US Medicaid coverage for stim MAT expanded to 40 states by 2023 per KFF
23
Ibogaine pilot for meth addiction showed 50% reduction in craving per NZ study
24
Global WHO essential medicines list includes nicotine replacement for stim cessation
Interpretation
Policy and Treatment Interpretation
The staggering economic and human toll of stimulant addiction reveals a system hemorrhaging nearly $200 billion annually, yet the path forward is illuminated by clear evidence that integrating medical interventions like contingency management and CBT with robust policy measures could dramatically stem the tide.
More related reading
04 · Category
Prevalence and Usage30 stats
01
In 2021, an estimated 2.7 million people aged 12 or older in the US misused prescription stimulants in the past year according to NSDUH data
02
Lifetime prevalence of cocaine use among US adults aged 18-25 was 18.9% in 2020 per NSDUH
03
In 2022, 1.1% of US adolescents aged 12-17 reported past-year stimulant misuse per Monitoring the Future survey
04
Global lifetime prevalence of amphetamine-type stimulant use is 1.2% among adults aged 15-64 according to UNODC World Drug Report 2023
05
In Europe, 1.3 million young adults aged 15-34 used ecstasy (MDMA stimulant) in the last year per EMCDDA 2023 report
06
US past-month cocaine use among adults rose to 2.0 million people in 2021 per NSDUH
07
Methamphetamine past-year use in US was 2.5 million people aged 12+ in 2021 per NSDUH
08
Among US college students, 5.6% reported non-medical use of Adderall in past year per 2022 Monitoring the Future
09
In Australia, 1.4% of population aged 14+ used methamphetamine in past 12 months per 2022-2023 National Drug Strategy Household Survey
10
UK lifetime cocaine use prevalence among 16-59 year olds is 11.3% per Crime Survey England and Wales 2022/23
11
In 2020, 0.4% of US population aged 12+ had past-year khat use, a stimulant, per NSDUH
12
Canadian past-year cocaine use among adults 20-24 was 4.3% in 2019 per CCDCS
13
In Brazil, 2.1% of urban population reported lifetime crack cocaine use per 2015 national survey
14
Past-year methamphetamine use in New Zealand was 1.0% among adults per 2019/20 NZ Health Survey
15
In South Africa, 1.5% of adults reported past-year methamphetamine use per 2017 SACENDU report
16
US emergency department visits for cocaine in 2021 totaled 505,000 per DAWN
17
Prescription stimulant misuse among US high school seniors was 3.2% past year in 2022 per MTF
18
Global cocaine use disorder affects 0.4% of adults 15-64 per UNODC 2023
19
In 2021, 1.8 million US young adults aged 18-25 misused stimulants past year per NSDUH
20
Ecstasy use last month among US 12th graders was 1.5% in 2022 per MTF
21
In Germany, 1.1% of 12th graders reported lifetime amphetamine use per ESPAD 2019
22
Past-year prescription stimulant misuse in US males aged 18-25 was 7.4% in 2021 per NSDUH
23
In Mexico, 1.2% of population aged 12-65 used methamphetamine past year per 2016-17 ENCODAT
24
US past-year nonmedical use of Ritalin among adults was 0.3% in 2021 per NSDUH
25
Lifetime caffeine consumption as stimulant exceeds 90% globally per WHO
26
In Japan, 0.3% of population reported methamphetamine use disorder per 2020 survey
27
US college students reporting Adderall use for studying: 10.2% lifetime per 2021 study
28
In 2022, 0.7% of EU young adults used amphetamines last year per EMCDDA
29
Past-month cocaine use in US adults 26+ was 0.7% in 2021 per NSDUH
30
Global khat use prevalence is 10 million users annually per UNODC
Interpretation
Prevalence and Usage Interpretation
Behind every statistic touting "moderate" stimulant use, from college Adderall to weekend cocaine, lies a formidable, multi-billion dollar public health crisis masquerading as personal choice.
05 · Category
Psychological Effects25 stats
01
Stimulants induce euphoria but paranoia in 40% of users after 24 hours per self-report
02
Chronic cocaine use leads to depression in 50-60% of abstinent users per longitudinal study
03
Methamphetamine psychosis mimics schizophrenia in 30-50% of heavy users per DSM case reviews
04
Adderall misuse for cognitive enhancement causes anxiety in 25% of students per survey
05
MDMA users report 20% higher rates of PTSD symptoms post-use per trauma studies
06
Stimulant withdrawal features dysphoria lasting 1-2 weeks in 70% of dependent users per DSM-5
07
Cocaine binging leads to 35% incidence of hallucinatory experiences per lab studies
08
Amphetamine-induced mania occurs in 10-20% of bipolar patients per psychopharm review
09
Chronic stimulant use correlates with 2.5-fold increase in suicide attempts per meta-analysis
10
Caffeine overdose causes panic attacks in 15% of high-dose users per ED data
11
Meth users exhibit 40% higher impulsivity scores on Barratt scale per neuropsych testing
12
Post-cocaine anhedonia persists 3-6 months in 60% of quitters per fMRI reward studies
13
Stimulants exacerbate ADHD symptoms rebound in 30% off-medication per clinical trials
14
Khat use linked to hypomania in 25% of regular chewers per East African studies
15
MDMA neurotoxicity causes memory deficits in 20-30% long-term users per cognitive tests
16
Cocaine dependence features craving intensity rated 8/10 by 80% during abstinence per VAS scales
17
Amphetamine sleep deprivation leads to cognitive impairment equivalent to 48h awake in 90% per PVT
18
Chronic meth use impairs emotional recognition accuracy by 25% per facial affect tasks
19
Stimulant users show 50% reduced decision-making performance on IGT per neuroeconomics
20
Post-MDMA depression hits 40% within 1 week per partygoer surveys
21
Nicotine withdrawal irritability affects 50% of quitters peaking day 3 per TTURC data
22
High-dose stimulants induce OCD-like compulsions in 15% per case series
23
Cocaine users have 3-fold higher rates of antisocial personality disorder per NESARC
24
Methamphetamine accelerates cognitive aging by 5-10 years per neurocognitive batteries
25
Adderall in non-ADHD causes hyperfocus but 20% report derealization per user studies
Interpretation
Psychological Effects Interpretation
The temporary euphoria of stimulants is a devil's bargain, trading fleeting focus for a lasting ledger of anxiety, psychosis, and profound emptiness that can echo for months.
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
Julian Richter. (2026, February 13). Stimulants Statistics. Gitnux. https://gitnux.org/stimulants-statistics
MLA
Julian Richter. "Stimulants Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/stimulants-statistics.
Chicago
Julian Richter. 2026. "Stimulants Statistics." Gitnux. https://gitnux.org/stimulants-statistics.
Sources & references
26 datasets cited across this report · attribution is report-level